publicações selecionadas
- Validação da Escala de Adesão à Terapia Imunossupressora (ITAS), em português brasileiro para receptores de transplante hepático.
- Adesão terapêutica em portadores de hepatite C crônica tratados com novos inibidores de protease
- Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1
- Letter to the Editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
- Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Adesão medicamentosa e seus correlatos clínicos em pacientes psiquiátricos e não-psiquiátricos.
- Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study
- Esketamine for Unipolar Major Depression With Psychotic Features
- Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study
- Validação em Português e Adaptação Transcultural da Escala de Adesão para Terapia imunossupressora (ITAS) em pacientes transplantados de fígado
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- Psychometric Properties the of Brazilian-Portuguese Version of Snaith-Hamilton Pleasure Scale (SHAPS)
- Letter to the editor about -comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression-
- Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial
- Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
- Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial